International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 1169-1173 doi: 10.5281/zenodo.17010456
Original Article
Compliance with Deep Vein Thrombosis Prophylaxis in Critically Ill Patients: A Clinical Audit from a Tertiary Care Hospital
 ,
 ,
Received
July 15, 2025
Accepted
Aug. 15, 2025
Published
Aug. 31, 2025
Abstract

Background: Deep vein thrombosis (DVT) is a significant cause of morbidity and mortality in critically ill patients. Early risk assessment and timely prophylaxis are recommended by the Indian Society of Critical Care Medicine (ISCCM) to prevent DVT. This clinical audit aimed to evaluate compliance with DVT prophylaxis standards in a tertiary care ICU.

Material and Methods: This prospective audit included 59 critically ill patients admitted to the ICU. Data on demographics, primary diagnoses, DVT risk factors, contraindications, and prophylaxis practices were collected. Risk assessment within 24 hours, type and timing of prophylaxis, and documentation of contraindications were compared against ISCCM guidelines.

Results: Patients ranged from 11 to 90 years, with the majority in the 61–70 years age group (25.42%). Male patients comprised 52.54%, and 28.81% had recent surgical interventions. Primary diagnoses included neurological (18.64%), respiratory (16.95%), and cardiovascular disorders (15.25%). Within 24 hours, 86.44% of patients had at least one risk factor for DVT; 13.56% had no risk factors, which were documented. Contraindications to pharmacological prophylaxis were present in 44.07% and to mechanical prophylaxis in 55.93% of patients. Prophylaxis was administered to 23 patients (30.51% pharmacological, 6.78% mechanical, 1.69% both), while 61.02% did not receive prophylaxis due to contraindications. Timing of prophylaxis initiation was within 24 hours in 22.03% and after 24 hours in 16.95%. All patients had documented risk assessment and clearly recorded contraindications, reflecting 100% compliance with ISCCM standards.

Conclusion: The audit demonstrates excellent adherence to ISCCM guidelines in risk assessment, prophylaxis administration, and documentation. Structured protocols effectively ensure safe and guideline-compliant DVT prevention in critically ill patients

Keywords
INTRODUCTION

Deep vein thrombosis (DVT) is a significant cause of morbidity and mortality in critically ill patients. The Indian Society of Critical Care Medicine (ISCCM) recommends that all critically ill patients receive pharmacological thromboprophylaxis for DVT prevention if the risk of DVT outweighs the risk of bleeding. Despite these guidelines, adherence to DVT prophylaxis protocols remains suboptimal in many healthcare settings. A study conducted in a tertiary care hospital in India found that only 69.9% of patients received appropriate thromboprophylaxis, indicating a gap in guideline adherence [1,2].

A systematic approach to venous thromboembolism (VTE) prevention, incorporating risk assessment upon hospital admission, has been shown to reduce morbidity and mortality. However, studies indicate that a significant proportion of hospitalized patients do not receive appropriate VTE prophylaxis within the recommended time frame. A multinational cross-sectional study revealed that only 58% of surgical patients and 37% of medical patients received recommended prophylaxis, highlighting the need for improved compliance [3-5].

Implementing quality improvement initiatives, such as standardized risk assessment protocols and staff education, has been effective in improving compliance with DVT prophylaxis guidelines. A study demonstrated that a quality improvement project increased compliance with perioperative thromboprophylaxis from 69.9% to 88.4%, emphasizing the importance of structured interventions [6].

 

Given the high risk of DVT in critically ill patients and the associated complications, it is imperative to evaluate and improve compliance with prophylaxis protocols. This study aims to assess adherence to ISCCM guidelines for DVT prophylaxis in a tertiary care ICU setting, providing insights into current practices and identifying areas for improvement.

 

MATERIAL AND METHODS

Study Design and Setting: This study was conducted as a prospective clinical audit in the intensive care unit (ICU) of a tertiary care teaching hospital. The audit was designed to evaluate compliance with the Indian Society of Critical Care Medicine (ISCCM) guidelines [7] for deep vein thrombosis (DVT) prophylaxis among critically ill patients.

 

Study Duration: The audit was carried out over a period of one month, preceded by one week of preparatory planning and followed by one week of data analysis.

 

Study Population: All adult patients admitted to the ICU during the study period were eligible for inclusion. Patients were excluded if their ICU stay was less than 24 hours or if they were already receiving therapeutic anticoagulation at the time of admission.

 

Data Collection

Data were obtained from patients’ medical records using a structured data collection form developed in Google Forms. The form was designed to capture the following information:

  • Demographic details (age, sex, and primary diagnosis).
  • Date and time of ICU admission.
  • Documentation of DVT risk assessment within 24 hours of ICU admission (Yes/No).
  • Type of prophylaxis administered (pharmacological, mechanical, or none).
  • Timing of initiation of prophylaxis.
  • Documentation of contraindications, if present.

 

Audit Standards

Compliance was assessed against ISCCM standards, which specify that:

  1. All ICU patients should undergo a documented DVT risk assessment within 24 hours of admission.
  2. Appropriate prophylaxis (either pharmacological or mechanical) should be prescribed and administered unless contraindicated.
  3. Contraindications to pharmacological prophylaxis must be clearly documented.
    The benchmark for each criterion was set at 100% compliance.

 

Data Analysis: Collected data were entered into Microsoft Excel and analyzed using descriptive statistics. Compliance rates were calculated as percentages and presented through charts and tables. These were compared against the ISCCM benchmark standards to identify gaps in practice.

 

RESULTS

A total of 59 critically ill patients were included in the study. The age of patients ranged from 11 to 90 years, with the majority falling in the 61–70 years age group (25.42%), followed by 71–80 years (20.34%). Gender distribution was slightly male-predominant. Among the participants, 17 patients (28.81%) had a recent history of surgical intervention. The primary diagnoses were diverse, with neurological disorders observed in 11 patients (18.64%), respiratory disorders in 10 (16.95%), cardiovascular disorders in 9 (15.25%), and hepatic/gastrointestinal disorders in 8 (13.56%) (Table 1).

 

Table 1: Basic profile of patients under study

Age Group (Years)

n

%

11-20

3

5.08

21-30

5

8.47

31-40

7

11.86

41-50

6

10.17

51-60

10

16.95

61-70

15

25.42

71-80

12

20.34

81-90

1

1.69

Gender

 

 

Female

28

47.46

Male

31

52.54

Post op patient with history of recent surgical intervention

 

 

Yes

17

28.81

No

42

71.19

Primary Diagnosis

 

 

Neurological Disorders

11

18.64

Cardiovascular Disorders

9

15.25

Respiratory Disorders

10

16.95

Renal Disorders

5

8.47

Hepatic / Gastrointestinal Disorders

8

13.56

Hematological / Oncological Disorders

5

8.47

Trauma / Orthopedic Disorders

5

8.47

Obstetric / Gynecological Disorders

3

5.08

Infectious / Sepsis

3

5.08

 

Within the first 24 hours of admission, 51 patients (86.44%) presented with at least one risk factor for DVT. Acute respiratory failure (20.34%), trauma (13.56%), and recent major surgery (13.56%) were the most frequently identified risk factors. Eight patients (13.56%) did not exhibit any identifiable risk factors (Table 2).

 

Table 2: Risk assessment within 24 hours

Condition / Risk Factor

n

%

Acute kidney injury

5

8.47

Acute respiratory failure

12

20.34

Bleeding

1

1.69

Bronchoscopy

1

1.69

CML - Blast crisis

1

1.69

CV stroke

2

3.39

Heart failure

1

1.69

Major surgery

8

13.56

Pregnancy

1

1.69

Prior thromboembolism

2

3.39

Prolonged immobilization

3

5.08

Rapid progressive quadriparesis

1

1.69

Sepsis

3

5.08

Septic shock

2

3.39

Trauma

8

13.56

None

8

13.56

Total

59

100.00

 

Among the patients, 26 (44.07%) had contraindications to pharmacological prophylaxis due to bleeding risk, whereas 33 patients (55.93%) had contraindications to mechanical prophylaxis (Table 3).

 

Table 3: Contraindications to DVT prophylaxis present in patients

Contraindication

n

%

Contraindication to pharmacological prophylaxis (Bleeding risk)

26

44.07

Contraindication to mechanical prophylaxis

33

55.93

Prophylaxis was not administered in 36 patients (61.02%). Pharmacological prophylaxis alone was given to 18 patients (30.51%), mechanical prophylaxis alone to 4 patients (6.78%), and combined prophylaxis to 1 patient (1.69%). Regarding timing, prophylaxis was initiated within 24 hours of admission in 13 patients (22.03%) and after 24 hours in 10 patients (16.95%) (Table 4).

Table 4: Details of DVT Prophylaxis given

Type of DVT Prophylaxis given

n

%

Pharmacological

18

30.51

Mechanical

4

6.78

Both

1

1.69

Not given

36

61.02

Total

59

100.00

Timing of DVT Prophylaxis

n

%

Within 24 hours

13

22.03

After 24 hours

10

16.95

 

All 59 patients had documented DVT risk assessments within 24 hours of ICU admission, achieving 100% compliance. Prophylaxis was appropriately administered to 23 patients, while 36 patients did not receive it due to documented contraindications, reflecting full compliance. All pharmacological contraindications were clearly recorded, demonstrating complete adherence to ISCCM standards (Table 5).

 

Table 5: Comparison of Audit Results with Compliance Standards

Compliance Standard

Requirement

Study Findings

Compliance (%)

Observations / Comments

1. DVT Risk Assessment

All ICU patients should have a documented DVT risk assessment within 24 hours of admission.

All 59 patients (100%) had documented risk assessments within 24 hours.

100%

Full compliance. Even patients without risk factors were documented as having none.

2. Appropriate Prophylaxis

Pharmacological or mechanical prophylaxis should be prescribed and administered unless contraindicated.

23 patients (38.98%) received prophylaxis; 36 patients (61.02%) did not receive prophylaxis due to documented contraindications.

100%

Full compliance. Non-administration was justified by contraindications.

3. Documentation of Contraindications

Contraindications to pharmacological prophylaxis should be clearly documented.

All contraindications were clearly documented for the patients concerned.

100%

Full compliance.

 

DISCUSSION

This study assessed adherence to the ISCCM guidelines for DVT prophylaxis in a tertiary care ICU setting. Our findings demonstrate exemplary compliance with the recommended protocols, aligning with previous studies that highlight the importance of structured interventions in improving prophylaxis practices. Notably, 100% of patients had documented DVT risk assessments within 24 hours of ICU admission, surpassing the 95% compliance observed in a multicenter study in India. This achievement underscores the effectiveness of standardized risk assessment protocols in enhancing adherence to guidelines.

 

Regarding prophylaxis administration, 38.98% of patients received appropriate prophylaxis, while 61.02% did not due to documented contraindications. This pattern is consistent with findings from a study in a tertiary care center, where 55% of ICU patients did not receive prophylaxis due to contraindications. The high percentage of non-administration due to contraindications reflects cautious clinical decision-making [7,8].

 

Furthermore, all contraindications were clearly documented, aligning with best practices emphasized in the ISCCM consensus statement. Clear documentation is crucial for ensuring patient safety and facilitating communication among healthcare providers [1,9]. In contrast, a study in a tertiary care hospital found that only 69.9% of patients received appropriate thromboprophylaxis, indicating variability in adherence to guidelines. Such discrepancies highlight the need for continuous monitoring and quality improvement initiatives to maintain high compliance rates [10].

 

Implementing educational interventions has proven effective in improving adherence to DVT prophylaxis guidelines. A study demonstrated that educational programs significantly enhanced critical care nurses' adherence to clinical practice guidelines for preventing venous thromboembolism. These findings suggest that ongoing staff education is vital for sustaining high compliance levels [11,12].

 

This study has several limitations. First, it was conducted in a single tertiary care ICU, which may limit the generalizability of the findings to other hospitals or healthcare settings. Second, the sample size was relatively small, restricting the statistical power for subgroup analyses. Third, the audit focused only on documented compliance and did not evaluate patient outcomes such as actual incidence of DVT or bleeding complications. Finally, data collection relied on medical records, which could be subject to documentation bias, although all contraindications and risk assessments were clearly recorded. Future multicenter studies with larger sample sizes and longitudinal follow-up are warranted to better assess the clinical impact of DVT prophylaxis practices.

 

CONCLUSION

This clinical audit demonstrates that ICU patients in our study consistently underwent timely DVT risk assessment, with all contraindications to prophylaxis clearly documented. Pharmacological or mechanical prophylaxis was appropriately administered in accordance with individual patient risk and contraindications, achieving full compliance with ISCCM standards. The findings highlight the effectiveness of structured protocols in ensuring guideline-adherent DVT prevention in critically ill patients and underscore the importance of continued adherence to risk assessment and documentation practices to maintain patient safety.

 

REFERENCES

  1. Jagiasi BG, Chhallani AA, Dixit SB, Kumar R, Pandit RA, Govil D, et al. Indian Society of Critical Care Medicine Consensus Statement for Prevention of Venous Thromboembolism in the Critical Care Unit. Indian J Crit Care Med. 2022 Oct;26(Suppl 2):S51-S65. doi: 10.5005/jp-journals-10071-24195.
  2. Imtiaz H, Nguyen TV, Vy Thai TT, Kouklidis G, Horgan M, Vijayaraghavan R. Evaluating the Compliance to 24-Hour Venous Thromboembolism Risk Re-assessment Following Orthopaedic Surgery at a Tertiary Center: A Closed-Loop Clinical Audit. Cureus. 2024 Nov 30;16(11):e74882. doi: 10.7759/cureus.74882.
  3. Naji Isaid E, Joudeh AI, Shereef N, Sirjuddin EH, Aboubaker N, Abdelfattah-Arafa E, et al. Enhancing venous thromboembolism prophylaxis compliance: a quality initiative for standardised risk assessment in a hospital setting. BMJ Open Qual. 2025 Jun 23;14(2):e003239. doi: 10.1136/bmjoq-2024-003239.
  4. Clapham RE, Marrinan E, Roberts LN. VTE prevention in medical inpatients – Current approach and controversies. Thrombosis Update. 2023;13:100151. doi:10.1016/j.tru.2023.100151.
  5. Clapham RE, Roberts LN. A systematic approach to venous thromboembolism prevention: a focus on UK experience. Res Pract Thromb Haemost. 2022 Dec 27;7(1):100030. doi: 10.1016/j.rpth.2022.100030.
  6. Arif A, Hussain MH, Shaikh F, Kim S, Khan MH. Evaluating and Improving Knowledge of DVT Prophylaxis Among Healthcare Professionals at a Tertiary Care Hospital in Karachi, Pakistan: A Quality Improvement Study. Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251345474. doi: 10.1177/10760296251345474.
  7. Yerramilli A, Katta S, Kidambi S, Kotari NK, Devulapally S, Sharma S. Deep vein thrombosis prophylaxis in a tertiary care center: An observational study. Apollo Med. 2016 Mar;13(1):37–41. doi: 10.1016/j.apme.2015.08.002.
  8. Gibson CD, Colvin MO, Park MJ, Lai Q, Lin J, Negassa A, et al. Prevalence and Predictors of Deep Vein Thrombosis in Critically Ill Medical Patients Who Underwent Diagnostic Duplex Ultrasonography. J Intensive Care Med. 2020 Oct;35(10):1062-1066. doi: 10.1177/0885066618813300.
  9. Javeri Y, Jagathkar G, Dixit S, Chaudhary D, Zirpe KG, Mehta Y, Govil D, Mishra RC, Samavedam S, Pandit RA, Savio RD, Clerk AM, Srinivasan S, Juneja D, Ray S, Sahoo TK, et al. Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020. Indian J Crit Care Med. 2020 Jan;24(Suppl 1):S6-S30. doi: 10.5005/jp-journals-10071-G23183.
  10. Pinjala R; ENDORSE-India investigators. Venous thromboembolism risk & prophylaxis in the acute hospital care setting (ENDORSE), a multinational cross-sectional study: results from the Indian subset data. Indian J Med Res. 2012 Jul;136(1):60-7.
  11. Mokadem NE, EL-Sayed S. Effect of educational intervention on critical care nurses' adherence to the clinical practice guidelines for preventing venous thromboembolism in critically ill patients. Am J Nurs Res. 2019;7(6):974–82. doi:10.12691/ajnr-7-6-10.
  12. Panda BK, Kumar V, Ketkar MN. Assessment of risk and prophylaxis for venous thromboembolism and adherence to the American College of Chest Physicians recommendations during early days of hospital stay at a tertiary care teaching hospital in a developing country. Indian J Vasc Endovasc Surg. 2017 Jul–Sep;4(3):107–11. doi:10.4103/ijves.ijves_7_17.
Recommended Articles
Research Article Open Access
Comparison Of Efficacy, Safety And Compliance Of Topical Clobetasol Propionate With Topical Calcipotriol In Chronic Psoriasis – A Prospective Double-Blind Study
2025, Volume-6, Issue-4 : 1154-1163
DOI: 10.5281/zenodo.17010313
Research Article Open Access
Histological Changes in Skin Biopsies of Patients with Psychogenic Dermatoses
2025, Volume-6, Issue-4 : 1115-1120
Research Article Open Access
A Prospective Cross-Sectional Study of Serum Electrolyte Changes in Diabetic Ketoacidosis
2025, Volume-6, Issue-4 : 1145-1160
Research Article Open Access
A study to map the primary sites of DFI onset and correlate these sites with specific initiating events
2025, Volume-6, Issue-4 : 1073-1078
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue-4
Citations
12 Views
18 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright IJMPR | All Rights Reserved